Sesderma, SL Dryses Aluminum Chlorohydrate Antiperspirant Recall

Why it was recalled

cGMP Deviations; product does not comply with cGMP requirements

Product description

Dryses Aluminum Chlorohydrate Antiperspirant Solution, 3.4 fl. oz (100 mL) bottle, over the counter, Manufactured by Sesderma S.L., Valencia, Spain, NDC 63181-0015-1, UPC 8 470003 244268

Lot numbers, UPCs & expiration codes

Lot code 40444601, exp 01/2019; Lot code 41414601, exp 05/2019; Lot code 40024602, exp 12/2018

Where it was sold

Distributed to following states: FL, PR, CO, GA.

What to do if you have this product

Compare the lot number and expiration date on your package with the codes above.
Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
If you have symptoms you think are related, contact your doctor. In an emergency call 911.
Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number: D-0842-2016
Classification: Class II
Status: Ongoing
Recall initiated: Oct 15, 2015
FDA report date: May 18, 2016
Quantity: 542 bottles
Recall type: Voluntary: Firm initiated
Recalling firm: Sesderma, SL

Original FDA data

Every field from FDA enforcement report D-0842-2016, exactly as published.

Show all FDA fields

City: Rafelbunol
Status: Ongoing
Country: Spain
Event ID: 73574
Address: Calle Massamagrell 3-5
Address (line 2): Poligono Industrial Rafelbunol
Code information: Lot code 40444601, exp 01/2019; Lot code 41414601, exp 05/2019; Lot code 40024602, exp 12/2018
Report date: May 18, 2016
Product type: Drugs
Recall number: D-0842-2016
Classification: Class II
Recalling firm: Sesderma, SL
Product quantity: 542 bottles
Reason for recall: cGMP Deviations; product does not comply with cGMP requirements
Voluntary / mandated: Voluntary: Firm initiated
Product description: Dryses Aluminum Chlorohydrate Antiperspirant Solution, 3.4 fl. oz (100 mL) bottle, over the counter, Manufactured by Sesderma S.L., Valencia, Spain, NDC 63181-0015-1, UPC 8 470003 244268
Distribution pattern: Distributed to following states: FL, PR, CO, GA.
Recall initiation date: Oct 15, 2015
Initial firm notification: Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Center classification date: May 10, 2016

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0842-2016, published May 18, 2016. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: Oct 2, 2026. Content last changed: Oct 2, 2026.

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.